Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pathophysiology and mechanism of long COVID: a comprehensive reviewAnnals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1473-1487 [Peer Reviewed Journal]2022 Belgian Health Care Knowledge Centre (KCE). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 Belgian Health Care Knowledge Centre (KCE). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 Belgian Health Care Knowledge Centre (KCE) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2076901 ;PMID: 35594336Full text available |
|
2 |
Material Type: Article
|
First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence gridAlexandria journal of medicine, 2018-12, Vol.54 (4), p.287-293 [Peer Reviewed Journal]2017 Alexandria University Faculty of Medicine ;2017 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. 2017 ;ISSN: 2090-5068 ;EISSN: 2090-5076 ;DOI: 10.1016/j.ajme.2017.09.001Full text available |
|
3 |
Material Type: Article
|
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccinesAnnals of medicine (Helsinki), 2022-12, Vol.54 (1), p.524-540 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2031274 ;PMID: 35132910Full text available |
|
4 |
Material Type: Article
|
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19:a meta-analysisAnnals of medicine (Helsinki), 2022-12, Vol.54 (1), p.516-523 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2034936 ;PMID: 35118917Full text available |
|
5 |
Material Type: Article
|
Series: Practical guidance to qualitative research. Part 3: Sampling, data collection and analysisThe European journal of general practice, 2018-01, Vol.24 (1), p.9-18 [Peer Reviewed Journal]2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 1381-4788 ;EISSN: 1751-1402 ;DOI: 10.1080/13814788.2017.1375091 ;PMID: 29199486Full text available |
|
6 |
Material Type: Article
|
Series: Practical guidance to qualitative research. Part 4: Trustworthiness and publishingThe European journal of general practice, 2018-01, Vol.24 (1), p.120-124 [Peer Reviewed Journal]2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 ;2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2018 The Author(s) ;ISSN: 1381-4788 ;EISSN: 1751-1402 ;DOI: 10.1080/13814788.2017.1375092 ;PMID: 29202616Full text available |
|
7 |
Material Type: Article
|
Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeAmyloid, 2018-10, Vol.25 (4), p.215-219 [Peer Reviewed Journal]2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2018.1549825Digital Resources/Online E-Resources |
|
8 |
Material Type: Article
|
Progressive fibrosing interstitial lung diseases: current practice in diagnosis and managementCurrent medical research and opinion, 2019-11, Vol.35 (11), p.2015-2024 [Peer Reviewed Journal]2019 Boehringer Ingelheim. Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2019.1647040Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6 - March 29, 2021Annals of medicine (Helsinki), 2021-01, Vol.53 (1), p.1419-1428 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1957998 ;PMID: 34482788Full text available |
|
10 |
Material Type: Article
|
Impact of COVID-19 pandemic on routine immunizationAnnals of medicine (Helsinki), 2021-01, Vol.53 (1), p.2286-2297 [Peer Reviewed Journal]2021 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.2009128 ;PMID: 34854789Full text available |
|
11 |
Material Type: Article
|
Sex differences in sequelae from COVID-19 infection and in long COVID syndrome: a reviewCurrent medical research and opinion, 2022-08, Vol.38 (8), p.1391-1399 [Peer Reviewed Journal]2022 Johnson & Johnson, LLC. Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 0300-7995 ;EISSN: 1473-4877 ;DOI: 10.1080/03007995.2022.2081454Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Diabetes type 2: relationships between lysosomal exocytosis of circulating normal-sized platelets and in vitro alpha-thrombin-evoked platelet responsesAnnals of medicine (Helsinki), 2023-12, Vol.55 (1), p.1102 [Peer Reviewed Journal]ISSN: 0785-3890 ;ISSN: 1365-2060 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2171108Full text available |
|
13 |
Material Type: Article
|
Validation of the 2011 and 2016 American college of rheumatology diagnostic criteria for fibromyalgia in a Chinese populationAnnals of medicine (Helsinki), 2023-12, Vol.55 (2), p.2249921-2249921 [Peer Reviewed Journal]2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2023 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2023.2249921 ;PMID: 37634058Full text available |
|
14 |
Material Type: Article
|
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committeeAmyloid, 2020-10, Vol.27 (4), p.217-222 [Peer Reviewed Journal]2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 1350-6129 ;ISSN: 1744-2818 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2020.1835263Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
Understanding modern-day vaccines: what you need to knowAnnals of medicine (Helsinki), 2018-02, Vol.50 (2), p.110-120 [Peer Reviewed Journal]2017 GlaxoSmithKline Biologicals S.A. Published by Informa UK Limited, trading as Taylor & Francis Group. 2017 ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2017.1407035Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Renal complications in COVID-19: a systematic review and meta-analysisAnnals of medicine (Helsinki), 2020-10, Vol.52 (7), p.345-353 [Peer Reviewed Journal]2020 Informa UK Limited, trading as Taylor & Francis Group 2020 ;2020 Informa UK Limited, trading as Taylor & Francis Group 2020 Informa UK Limited, trading as Taylor & Francis Group ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2020.1790643 ;PMID: 32643418Full text available |
|
17 |
Material Type: Article
|
The reported effects of the COVID-19 pandemic on people with intellectual disability and their carers: a scoping reviewAnnals of medicine (Helsinki), 2021-01, Vol.53 (1), p.786-804 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1922743 ;PMID: 34110258Full text available |
|
18 |
Material Type: Article
|
Influence of gut microbiota on eye diseases: an overviewAnnals of medicine (Helsinki), 2021-01, Vol.53 (1), p.750-761 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2021 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2021.1925150 ;PMID: 34042554Full text available |
|
19 |
Material Type: Article
|
Global, regional and national burden of gastroesophageal reflux disease, 1990-2019: update from the GBD 2019 studyAnnals of medicine (Helsinki), 2022-12, Vol.54 (1), p.1372-1384 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890.2022.2074535 ;PMID: 35579516Full text available |
|
20 |
Material Type: Article
|
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trialAmyloid, 2023-01, Vol.30 (1), p.18-26 [Peer Reviewed Journal]2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 1350-6129 ;EISSN: 1744-2818 ;DOI: 10.1080/13506129.2022.2091985Digital Resources/Online E-Resources |